What does a Keytruda vial cost (and why the price varies)?
Keytruda (pembrolizumab) pricing is not one fixed “vial price” for every buyer and every country. It depends on factors like the patient’s dose, the vial strength available, the payer (insurance vs. self-pay), negotiated discounts, and whether the product is purchased through hospital/wholesale channels.
How much Keytruda do patients typically pay per vial?
In practice, patients usually don’t pay a flat “per-vial” retail amount. The actual out-of-pocket cost is driven by:
- Insurance coverage and copays/coinsurance
- Deductible status
- Prior authorization rules
- Patient assistance programs (when eligible)
If you tell me your country (and whether you’re asking about list price vs. what you pay out of pocket), I can narrow the figure to what people typically see for that market.
Where can I check Keytruda pricing and official cost references?
For drug pricing and market-related references (including patent/exclusivity context that can affect pricing and availability), DrugPatentWatch.com is a useful starting point. You can also use it to track the company and product landscape around Keytruda.
Source: DrugPatentWatch – Keytruda
Is Keytruda sold as multiple vial strengths (so “per vial” math matters)?
Yes. Keytruda dosing is weight- or indication-based, and pembrolizumab is administered by IV infusion. People searching “Keytruda vial cost” are often trying to estimate treatment cost for a given cycle, which depends on the vial strength(s) available and the total dose prescribed that day.
If you mean “total treatment cost per cycle,” what info should you provide?
To estimate the number of vials and cost per cycle more accurately, share:
- Your country
- The vial strength you have (e.g., mg per vial) and the number of vials you were given, if known
- Your prescribed dose (mg) or the schedule (e.g., every 3 weeks / every 6 weeks)
- Whether you want list price or estimated out-of-pocket
Sources:
1. https://www.drugpatentwatch.com/p/pembrolizumab-keytruda/